Novo Nordisk Foundation partners with CARB-X to fight drug-resistant infections
"Like CARB-X, the Novo Nordisk Foundation is committed to driving innovation in the fight against drug-resistant infections," says Peter Lawætz Andersen, Senior Vice President, Infectious Diseases at the Foundation.
- "Like CARB-X, the Novo Nordisk Foundation is committed to driving innovation in the fight against drug-resistant infections," says Peter Lawætz Andersen, Senior Vice President, Infectious Diseases at the Foundation.
- The grant is also part of a broader commitment from the Foundation and Novo Holdings to fight drug resistance through the development of innovative products.
- The Foundation is also funding a major new initiative – the Novo Nordisk Foundation Initiative for Vaccines and Immunity – that will reduce the use of antibiotics and thus the spread of AMR by developing vaccines against respiratory infections.
- With this grant, the Novo Nordisk Foundation joins major governments and foundations in supporting the work of CARB-X.